Literature DB >> 30100549

Renaming low risk conditions labelled as cancer.

Brooke Nickel1,2, Ray Moynihan1,3, Alexandra Barratt1, Juan P Brito4, Kirsten McCaffery5,2.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30100549     DOI: 10.1136/bmj.k3322

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

1.  The elusive diagnosis of cancer: testing times.

Authors:  Brian D Nicholson; Rafael Perera; Matthew J Thompson
Journal:  Br J Gen Pract       Date:  2018-11       Impact factor: 5.386

2.  The Use of Digital Pathology and Artificial Intelligence in Histopathological Diagnostic Assessment of Prostate Cancer: A Survey of Prostate Cancer UK Supporters.

Authors:  Kai Rakovic; Richard Colling; Lisa Browning; Monica Dolton; Margaret R Horton; Andrew Protheroe; Alastair D Lamb; Richard J Bryant; Richard Scheffer; James Crofts; Ewart Stanislaus; Clare Verrill
Journal:  Diagnostics (Basel)       Date:  2022-05-13

3.  The impact of the illness label 'gout' on illness and treatment perceptions in Māori (Indigenous New Zealanders).

Authors:  Nicola Dalbeth; Meihana Douglas; Kate MacKrill; Leanne Te Karu; Maria Kleinstäuber; Keith J Petrie
Journal:  BMC Rheumatol       Date:  2020-04-15

4.  Ethical Issues of Digital Twins for Personalized Health Care Service: Preliminary Mapping Study.

Authors:  Pei-Hua Huang; Ki-Hun Kim; Maartje Schermer
Journal:  J Med Internet Res       Date:  2022-01-31       Impact factor: 5.428

5.  Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus?

Authors:  Caitlin R Semsarian; Tara Ma; Brooke Nickel; Richard A Scolyer; Peter M Ferguson; H Peter Soyer; Lisa Parker; Alexandra Barratt; John F Thompson; Katy J L Bell
Journal:  Br J Dermatol       Date:  2022-04-07       Impact factor: 11.113

6.  Media coverage of calls to rename low-risk cancers: a content analysis.

Authors:  Brooke Nickel; Ray Moynihan; Alexandra Barratt; Juan P Brito; Kirsten McCaffery
Journal:  BMJ Open       Date:  2020-07-19       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.